Zealand Pharma launches major US research hub in Cambridge, Massachusetts
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
The Phase 1 single and multiple ascending dose study is set to begin dosing in early Q1 2026
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
India plays a critical role in Bristol Myers Squibb’s global strategy
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Subscribe To Our Newsletter & Stay Updated